Acadian Asset Management’s Psychemedics Corporation PMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-21,709
Closed -$110K 2367
2020
Q4
$110K Sell
21,709
-22,512
-51% -$97.7K ﹤0.01% 1720
2020
Q3
$195K Sell
44,221
-3,111
-7% -$15.2K ﹤0.01% 1458
2020
Q2
$262K Hold
47,332
﹤0.01% 1405
2020
Q1
$287K Buy
47,332
+5,684
+14% +$47.9K ﹤0.01% 1108
2019
Q4
$379K Buy
41,648
+674
+2% +$6.23K ﹤0.01% 1142
2019
Q3
$372K Buy
40,974
+1,446
+4% +$12.3K ﹤0.01% 1166
2019
Q2
$399K Sell
39,528
-14,128
-26% -$160K ﹤0.01% 1068
2019
Q1
$752K Sell
53,656
-10,068
-16% -$173K ﹤0.01% 993
2018
Q4
$1.01M Sell
63,724
-1,709
-3% -$29.5K 0.01% 726
2018
Q3
$1.23M Buy
65,433
+759
+1% +$15.1K 0.01% 673
2018
Q2
$1.24M Sell
64,674
-5,188
-7% -$105K 0.01% 681
2018
Q1
$1.49M Sell
69,862
-5,287
-7% -$110K 0.01% 645
2017
Q4
$1.54M Sell
75,149
-8,159
-10% -$151K 0.01% 607
2017
Q3
$1.53M Buy
83,308
+12,316
+17% +$271K 0.01% 609
2017
Q2
$1.77M Sell
70,992
-797
-1% -$16.8K 0.01% 593
2017
Q1
$1.44M Buy
71,789
+19,711
+38% +$433K 0.01% 701
2016
Q4
$1.28M Buy
52,078
+41,162
+377% +$923K 0.01% 677
2016
Q3
$217K Buy
+10,916
New +$202K ﹤0.01% 954

Other funds holding PMD

Acadian Asset Management's PMD Position: Q1 2021 in Review

Acadian Asset Management sold out of Psychemedics Corporation (PMD) in Q1 2021, closing a stake of 21,709 shares — an estimated $110K sold.

Acadian Asset Management first reported a position in PMD in Q3 2016 and held it in 18 quarters. The position peaked at $1.77M in Q2 2017. 31 funds tracked by Wall St. Rank hold PMD as of Q1 2021.

  • Acadian Asset Management reported no remaining Psychemedics Corporation position as of Q1 2021 after selling out during the quarter.
  • Acadian Asset Management sold 21,709 Psychemedics Corporation shares in Q1 2021, an estimated $110K.
  • Acadian Asset Management first reported a position in Psychemedics Corporation in Q3 2016 and held it in 18 quarters.
  • Acadian Asset Management's Psychemedics Corporation position peaked at $1.77M in Q2 2017.
  • 31 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q1 2021.

Based on Acadian Asset Management's 13F filing for Q1 2021, filed 11 May 2021.